🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized phase II trial studies how well nivolumab works with or wit...
Status
Completed
Location
Sutter Auburn Faith Hospital
Start Date
2015-08-10
Trial ID
NCT02498600
Treatments Being Tested
This phase II trial investigates the side effects of tocilizumab, ipilimuma...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-09-23
Trial ID
NCT04940299
Treatments Being Tested
This phase I/Ib trial is to find out the best dose, possible benefits and/o...
Status
Suspended
Location
National Cancer Institute Developmental Therapeutics Clinic
Start Date
2022-02-02
Trial ID
NCT04840589
This randomized phase II trial is studying how well giving ipilimumab with ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2010-12-28
Trial ID
NCT01134614
Treatments Being Tested
This phase II trial compares the effect of immunotherapy with ipilimumab an...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2023-10-25
Trial ID
NCT05836571
This phase II trial studies how well ipilimumab works in treating patients ...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2012-12-03
Trial ID
NCT01693783
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of ipilimumab ...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2014-03-07
Trial ID
NCT01896999
This is a multicenter, open-label, multiple dose, dose escalation phase I s...
Status
Completed
Location
Border Medical Oncology Research Unit
Start Date
2018-04-26
Trial ID
NCT03523819
This phase II trial tests adding VSV-IFNβ-NIS to standard of care ipilimuma...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-04-21
Trial ID
NCT07510334
This phase I trial studies the side effects and best dose of anetumab ravta...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-12-09
Trial ID
NCT03816358